PL342453A1 - Biphenylsulphonylcyanamides, method of obtaining them and their application as drugs - Google Patents

Biphenylsulphonylcyanamides, method of obtaining them and their application as drugs

Info

Publication number
PL342453A1
PL342453A1 PL99342453A PL34245399A PL342453A1 PL 342453 A1 PL342453 A1 PL 342453A1 PL 99342453 A PL99342453 A PL 99342453A PL 34245399 A PL34245399 A PL 34245399A PL 342453 A1 PL342453 A1 PL 342453A1
Authority
PL
Poland
Prior art keywords
biphenylsulphonylcyanamides
drugs
obtaining
application
Prior art date
Application number
PL99342453A
Other languages
English (en)
Inventor
Heinz-Werner Kleemann
Hans-Jochen Lang
Jan-Robert Schwark
Andreas Weichert
Sabine Faber
Hans-Willi Jansen
Stefan Petry
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PL342453A1 publication Critical patent/PL342453A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
PL99342453A 1998-02-04 1999-02-04 Biphenylsulphonylcyanamides, method of obtaining them and their application as drugs PL342453A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19804251A DE19804251A1 (de) 1998-02-04 1998-02-04 Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
PCT/EP1999/000724 WO1999040064A1 (de) 1998-02-04 1999-02-04 Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament

Publications (1)

Publication Number Publication Date
PL342453A1 true PL342453A1 (en) 2001-06-04

Family

ID=7856542

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99342453A PL342453A1 (en) 1998-02-04 1999-02-04 Biphenylsulphonylcyanamides, method of obtaining them and their application as drugs

Country Status (19)

Country Link
US (1) US6369069B1 (enExample)
EP (1) EP1053224B1 (enExample)
JP (1) JP4464559B2 (enExample)
KR (1) KR100595353B1 (enExample)
CN (1) CN1231465C (enExample)
AR (1) AR016448A1 (enExample)
AT (1) ATE222584T1 (enExample)
AU (1) AU758154B2 (enExample)
BR (1) BR9907667A (enExample)
CA (1) CA2319555A1 (enExample)
DE (2) DE19804251A1 (enExample)
DK (1) DK1053224T3 (enExample)
ES (1) ES2182504T3 (enExample)
HU (1) HU224618B1 (enExample)
PL (1) PL342453A1 (enExample)
PT (1) PT1053224E (enExample)
RU (1) RU2247111C2 (enExample)
TR (1) TR200002255T2 (enExample)
WO (1) WO1999040064A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820064A1 (de) 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
US6906069B1 (en) 1999-01-08 2005-06-14 Amgen Inc. LXR modulators
AU2000235960A1 (en) * 2000-02-14 2001-08-27 Tularik, Inc. Lxr modulators
AU2001278480A1 (en) 2000-07-24 2002-02-05 Bayer Crop Science Ag Biphenyl carboxamides
AU2003208952B2 (en) 2002-01-30 2008-04-24 Amgen Inc. Heterocyclic arylsulfonamidobenzylic compounds
DE10206354A1 (de) * 2002-02-14 2003-08-28 Aventis Pharma Gmbh Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen
MX2008013194A (es) * 2006-04-11 2008-12-01 Vertex Pharma Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2062558A1 (en) * 1991-03-08 1992-09-09 Prasun K. Chakravarty Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
EP0586513A1 (en) * 1991-05-10 1994-03-16 Merck & Co. Inc. Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
FR2716883B1 (fr) * 1994-03-04 1996-04-26 Roussel Uclaf Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19741635A1 (de) 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament

Also Published As

Publication number Publication date
HUP0102576A1 (hu) 2002-03-28
RU2247111C2 (ru) 2005-02-27
ES2182504T3 (es) 2003-03-01
HU224618B1 (hu) 2005-11-28
EP1053224A1 (de) 2000-11-22
JP2002502840A (ja) 2002-01-29
WO1999040064A1 (de) 1999-08-12
KR100595353B1 (ko) 2006-07-03
HK1034706A1 (en) 2001-11-02
AU3139899A (en) 1999-08-23
AU758154B2 (en) 2003-03-13
DE19804251A1 (de) 1999-08-05
TR200002255T2 (tr) 2001-06-21
DE59902408D1 (de) 2002-09-26
EP1053224B1 (de) 2002-08-21
BR9907667A (pt) 2000-10-24
HUP0102576A3 (en) 2002-12-28
ATE222584T1 (de) 2002-09-15
PT1053224E (pt) 2002-12-31
CN1231465C (zh) 2005-12-14
US6369069B1 (en) 2002-04-09
JP4464559B2 (ja) 2010-05-19
DK1053224T3 (da) 2002-12-23
AR016448A1 (es) 2001-07-04
CA2319555A1 (en) 1999-08-12
KR20010040564A (ko) 2001-05-15
CN1289321A (zh) 2001-03-28

Similar Documents

Publication Publication Date Title
PL334337A1 (en) Derivatives of sulphonamides, method of obtaining them and their application as drugs
PL318277A1 (en) Novel substituted axazolydinones, method of obtaining and drugs containing them
PL330841A1 (en) Benzosulphonic derivatives, method of obtaining them and therapeutic agents containing such derivatives
PL341590A1 (en) Novel aromatic amides, method of obtaining them and their application as drugs
PL317929A1 (en) Pyrido-condenset thenyl- and furanyl oxazolydinones, method of obtaining and drugs containing them
IL136951A0 (en) Sustained-release composition, method of its production and use thereof
PL338143A1 (en) Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them
PL341435A1 (en) Compounds exhibiting antipicornaviral properties, method of obtaining such compounds and their application
PL318278A1 (en) Novel heteroaryl oxazolydinones, method of obtaining and drugs containing them
HUP0100347A3 (en) Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparation
PL321003A1 (en) Derivatives of piperasine, drugs containing them, their application and methods of obtaining them
ZA989207B (en) Method of building and maintaining bone.
PL341619A1 (en) Derivatives of cyclobutane, method of obtaining them and their therapeutic application
PL328824A1 (en) Novel triazolopurines, method of obtaining them and their application as drugs
PL331287A1 (en) Substituted derivatives of pyrazoyl-pyrazole, method of obtaining them and their application as herbicides
PL350902A1 (en) Pyridothiene diazepins, method of obtaining them and pharmacological compositions containing them
IL138904A0 (en) Magnetic- abrasive powder, and method of producing the same
PL331153A1 (en) Novel derivatives of erythromycin, method of obtaining them and their applications as drugs
PL325142A1 (en) Novel compounds-derivatives of benzoxazinodione, method of obtaining them and their application
HUP0001245A3 (en) Novel erythromycin derivatives, method of preparation and application as medicines
PL341012A1 (en) Derivatives of echinocandin, method of obtaining them and their applications as antimycotic agents
PL331444A1 (en) Derivatives of 11-acetyl-12,13-dioxabicyclo[8.2.1]tridecenone, method of obtaining them and drugs containing such compounds
PL334134A1 (en) Novel derivatives of erythromycin, method of obtaining them and their application as drugs
PL334144A1 (en) Novel derivatives of pyrolydine, composition containing and method of obtaining them
PL340644A1 (en) 1-methyl-5-alkylosulphonyl-, 1-methyl-5-alkylosulphinyl- and 1-methyl-5-alkylothio- substituted pyrazolylpyrazoles, method of obtaining them and their application as herbicides

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)